Albany - New York, Sept. 28, 2016 -- A market study on the global tourism market, recently published by Transparency Market Research (TMR) estimates this market to rise at an exceptional CAGR of 17.90% over the period from 2013 to 2019 and reach a value US$32.5 bn by the end of the forecast period.The research report, titled “Medical Tourism Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” states that the worldwide medical tourism market attained a value of US$10.5 bn in 2012.
Browse full Industry Research Report: http://www.transparencymarketresearch.com/medical-tourism.html
Medical tourism is defined as traveling from one location to another with a purpose to gain medical assistance. Generally, people from developing nations travel to developed countries for medical treatments that are unavailable in their own countries due to poor medical and healthcare infrastructure. However, in recent years, people residing in developed economies have also begun travelling to lesser developed countries in order to gain cost-efficient medical assistance.
According to this study, the falling cost of medical procedures in the Philippines, India, Singapore, Thailand, Mexico, Malaysia, Brazil, Turkey, Taiwan, South Korea, Poland, Costa Rica, and Dubai is encouraging people to travel to these countries for their treatment and, in turn, is propelling the global medical tourism market significantly.
In addition, the widening range of medical treatments available in these nations, coupled with technical advancements in the field of medical and healthcare, is likely to boost this market greatly during the forecast period, states the market report.
In this study, the global medical tourism market is analyzed on the basis of its regional spread. India, Singapore, Thailand, Malaysia, Brazil, Mexico, Turkey, Taiwan, and South Korea are the major medical tourism markets across the world.
Get Research PDF for more Professional and Technical Insights: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=900
Thailand has emerged as the most popular destination for cosmetic surgeries among the medical tourists from Western Europe. In 2012, this country had welcomed around 2.5 million foreign patients, accounting for approximately 45% of the overall number of foreign medical tourists arrived in Asia. However, Malaysia is likely to dominate the global medical tourism market in the coming years.
Almost 0.7 million patients were treated in this nation in 2012. Analysts expect around 2 mn patients to gain medical assistance in Malaysia by the end of the forecast period, notes the research report.
The report further states that India and Singapore are the most preferred destinations in case of complex medical procedures. India has attracted a large number of patients due to its increasing popularity in the field of cardiac treatments. Costa Rica, Dubai, Poland, and the Philippines have been identified as the prospective countries for medical tourism in this market study.
Samitivej Sukhumvit, Raffles Medical Group, Fortis Healthcare Ltd., Apollo Hospitals Enterprise Ltd., Bangkok Hospital Medical Center, Asian Heart Institute, Bumrungrad International Hospital, KPJ Healthcare Berhad, Min-Sheng General Hospital, and Prince Court Medical Center are some of the major organizations operating in the global medical tourism market.
Browse Press Release on Medical Tourism Market: http://www.transparencymarketresearch.com/pressrelease/medical-tourism.htm
The global medical tourism market is segmented into:
By Region
- India
- Thailand
- Singapore
- Malaysia
- Mexico
- Brazil
- Turkey
- South Korea
- Taiwan
- Prospective Countries
- Costa Rica
- Poland
- Dubai
- Philippines
Browse Other Research Reports:
- Traveler’s Diarrhea Market: http://www.transparencymarketresearch.com/travelers-diarrhea-market.html
- Mobility Scooter Market: http://www.transparencymarketresearch.com/mobility-scooter-market.html
- Care Management Solutions Market: http://www.transparencymarketresearch.com/care-management-solutions-market.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact Us: Rohit Bhisey Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 



